Method-dependent Changes in “HDL-Cholesterol” with Recombinant Apolipoprotein A-IMilano Infusion in Healthy Volunteers

Abstract
Warnick et al. (1) recently reviewed the status of the measurement of HDL-cholesterol (HDL-C) and cautioned against the use of the new homogeneous methods, when atypical specimens may be present, without additional validation of the accuracy of the methods. We recently had the opportunity to analyze specimens from a clinical trial, which will serve as an excellent example of the warning given by these authors.